Fusion Pharmaceuticals Current Assets

Fusion Pharmaceuticals (FUSN) currently reports a current assets of $220M as of March 2024. That compares with $220M in the prior-year period — up 0.1% year over year. Use the charts on this page to explore Fusion Pharmaceuticals's current assets history and peer comparisons.

Fusion Pharmaceuticals's current assets increased from $220M to $220M — a 0.1% year-over-year increase (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Fusion Pharmaceuticals reported $220M in current assets as of March 2024. That compares with $220M in the prior-year period — up 0.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $220M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Fusion Pharmaceuticals, and consider following FUSN for alerts when major investors trade the stock.

Fusion Pharmaceuticals is classified in the Healthcare sector. On current assets, it currently shows $220M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing FUSN with unrelated industries.